-
1
-
-
0034566462
-
Trends of IL-6 and IL-8 levels in patients with recurrent breast cancer: Preliminary report
-
Yokoe, T., Lino, Y., Morishita, Y., Trends of IL-6 and IL-8 levels in patients with recurrent breast cancer: preliminary report. Breast Cancer 7, 187 (2000)
-
(2000)
Breast Cancer
, vol.7
, pp. 187
-
-
Yokoe, T.1
Lino, Y.2
Morishita, Y.3
-
2
-
-
0033036097
-
Serum interleukin-6 levels correlate in tumor progression and prognosis in metastatic breast carcinoma
-
Zhuang, G. J., Adachi, I., Serum interleukin-6 levels correlate in tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res. 19, 142 (1999)
-
(1999)
Anticancer Res.
, vol.19
, pp. 142
-
-
Zhuang, G.J.1
Adachi, I.2
-
3
-
-
0033832167
-
An analysis of serum interleukin-6 levels to predict benefits of medroxyprogesterone acetate in advanced recurent breast cancer
-
Nishimura, R., Nagno, K., Miyayama, H. et al., An analysis of serum interleukin-6 levels to predict benefits of medroxyprogesterone acetate in advanced recurent breast cancer. Oncology 59, 166 (2000)
-
(2000)
Oncology
, vol.59
, pp. 166
-
-
Nishimura, R.1
Nagno, K.2
Miyayama, H.3
-
4
-
-
0028893151
-
Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non Hodgkin's lymphoma
-
Stasi, R., Zinzani, P. L., Galieni, P., et al, Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non Hodgkin's lymphoma. Eur. J. Haematol. 54, 9 (1995).
-
(1995)
Eur. J. Haematol.
, vol.54
, pp. 9
-
-
Stasi, R.1
Zinzani, P.L.2
Galieni, P.3
-
5
-
-
0028955069
-
Diagnostic value of serum IL-6 level in monoclonal gammopathies
-
DuVillard, L., Guiguet, M., Casasnovas, F. et al., Diagnostic value of serum IL-6 level in monoclonal gammopathies. Br. J. Haematol. 89, 243 (1995)
-
(1995)
Br. J. Haematol.
, vol.89
, pp. 243
-
-
DuVillard, L.1
Guiguet, M.2
Casasnovas, F.3
-
6
-
-
0027278569
-
Serum interleukin-6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms
-
Kurzrock, E., Redman, J., Cabanillas, F. et al., Serum interleukin-6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Cancer Res. 53, 2118 (1993)
-
(1993)
Cancer Res.
, vol.53
, pp. 2118
-
-
Kurzrock, E.1
Redman, J.2
Cabanillas, F.3
-
7
-
-
0021321199
-
Beta 2-microglobulin in myeloma: Optimal use for staging, prognosis and treatment. A prospective study of 160 patients
-
Bataille, R., Grenier, J., Sany, J., Beta 2-microglobulin in myeloma: optimal use for staging, prognosis and treatment. A prospective study of 160 patients. Blood 63, 468 (1984)
-
(1984)
Blood
, vol.63
, pp. 468
-
-
Bataille, R.1
Grenier, J.2
Sany, J.3
-
8
-
-
0036228576
-
Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does Viscum album treatment affect these parameters?
-
Kovacs, E., Kuehn, J. J., Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does Viscum album treatment affect these parameters? Biomed. Pharmacother. 56, 152 (2002)
-
(2002)
Biomed. Pharmacother.
, vol.56
, pp. 152
-
-
Kovacs, E.1
Kuehn, J.J.2
-
9
-
-
0344443295
-
How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2?
-
Kovacs, E., How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2? Biomed. Pharmacother. 57, 489 (2003)
-
(2003)
Biomed. Pharmacother.
, vol.57
, pp. 489
-
-
Kovacs, E.1
-
10
-
-
0022521830
-
A macrophag-derived factor required by plasmocytomas for survival and proliferation in vitro
-
Nordan, R., Potter, M., A macrophag-derived factor required by plasmocytomas for survival and proliferation in vitro. Science 233, 566 (1986)
-
(1986)
Science
, vol.233
, pp. 566
-
-
Nordan, R.1
Potter, M.2
-
11
-
-
0036242236
-
Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro
-
Maier, G., Fiebig, H. H., Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro. Anticancer Drugs 13, 373 (2002)
-
(2002)
Anticancer Drugs
, vol.13
, pp. 373
-
-
Maier, G.1
Fiebig, H.H.2
-
12
-
-
0028894133
-
Comparative study on the cytotoxic effect of viscotoxin and mistletoe lectin on tumour cells in vitro
-
Urech, K., Schaller, G., Ziska, P., Comparative study on the cytotoxic effect of viscotoxin and mistletoe lectin on tumour cells in vitro. Phytother. Res. 9, 49 (1995)
-
(1995)
Phytother. Res.
, vol.9
, pp. 49
-
-
Urech, K.1
Schaller, G.2
Ziska, P.3
-
13
-
-
0022514587
-
Effects of mistletoe (Viscum album L.) extracts on cultured tumour cells
-
Ribéreau-Gayon, G., Jung, M. L., Baudino, S. et al., Effects of mistletoe (Viscum album L.) extracts on cultured tumour cells. Experientia 42, 594 (1986)
-
(1986)
Experientia
, vol.42
, pp. 594
-
-
Ribéreau-Gayon, G.1
Jung, M.L.2
Baudino, S.3
-
14
-
-
0005728053
-
Direct cytotoxic effects of preparations used as unconventional methods in cancer therapy in human tumour xenografts in the clonogenic assay and in nude mice
-
Arnold, W., Kopf,-Maier, P., Micheel, B. (eds.), Karger, Basel
-
Berger, D. P., Dengler, W. A., Fiebig, H. H., Direct cytotoxic effects of preparations used as unconventional methods in cancer therapy in human tumour xenografts in the clonogenic assay and in nude mice. In: Immunodeficient animals: Models for Cancer Research, Arnold, W., Kopf,-Maier, P., Micheel, B. (eds.), vol. 51, Karger, Basel (1996)
-
(1996)
Immunodeficient Animals: Models for Cancer Research
, vol.51
-
-
Berger, D.P.1
Dengler, W.A.2
Fiebig, H.H.3
-
15
-
-
0027374994
-
In vitro effects of mistletoe extracts and mistletoe lectins: Cytotoxicity toward tumour cells and activated lymphocytes is due to the induction of programmed cell death (apoptosis)
-
Janssen, O., Scheffler, A., Kabelitz, D., In vitro effects of mistletoe extracts and mistletoe lectins: cytotoxicity toward tumour cells and activated lymphocytes is due to the induction of programmed cell death (apoptosis). Arzneim.-Forsch./Drug Res. 43, 1221 (1993)
-
(1993)
Arzneim.-Forsch./Drug Res.
, vol.43
, pp. 1221
-
-
Janssen, O.1
Scheffler, A.2
Kabelitz, D.3
-
16
-
-
0029093438
-
Effect of fetal calf serum on the cytotoxic activity of mistletoe (Viscum album L.) lectins in cell culture
-
Ribéreau-Gayon, G., Jung, M. L., Beck, J. P., Effect of fetal calf serum on the cytotoxic activity of mistletoe (Viscum album L.) lectins in cell culture. Phytother. Res. 9, 336 (1995)
-
(1995)
Phytother. Res.
, vol.9
, pp. 336
-
-
Ribéreau-Gayon, G.1
Jung, M.L.2
Beck, J.P.3
|